Start the conversation
ATAI Life Sciences will go public this week.
And investors wanting to cash in on one of the hottest medicine and mental health trends need to pay attention to this stock.
The ATAI IPO will raise around $100 million that the company can add to its already-sizeable cash on hand, about $97 billion as of the end of 2020.
ATAI stock could be the biggest psychedelic stock opportunity on the NASDAQ to date.